Anti-inflammatory adipokines: chemerin, vaspin, omentin concentrations and SARS-CoV-2 outcomes

Abstract Coronavirus disease 2019 (COVID-19) is associated with systemic inflammation. A wide range of adipokines activities suggests they influence pathogenesis and infection course. The aim was to assess concentrations of chemerin, omentin, and vaspin among COVID-19 patients with an emphasis on ad...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Michał Kukla, Tomasz Menżyk, Marcin Dembiński, Marek Winiarski, Aleksander Garlicki, Monika Bociąga-Jasik, Magdalena Skonieczna, Dorota Hudy, Barbara Maziarz, Beata Kusnierz-Cabala, Lubomir Skladany, Ivica Grgurevic, Małgorzata Wójcik-Bugajska, Tomasz Grodzicki, Dominika Stygar, Tomasz Rogula
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/ab7ee6424fed4bea89e7d91ef4bfec76
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:ab7ee6424fed4bea89e7d91ef4bfec76
record_format dspace
spelling oai:doaj.org-article:ab7ee6424fed4bea89e7d91ef4bfec762021-11-08T10:49:14ZAnti-inflammatory adipokines: chemerin, vaspin, omentin concentrations and SARS-CoV-2 outcomes10.1038/s41598-021-00928-w2045-2322https://doaj.org/article/ab7ee6424fed4bea89e7d91ef4bfec762021-11-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-00928-whttps://doaj.org/toc/2045-2322Abstract Coronavirus disease 2019 (COVID-19) is associated with systemic inflammation. A wide range of adipokines activities suggests they influence pathogenesis and infection course. The aim was to assess concentrations of chemerin, omentin, and vaspin among COVID-19 patients with an emphasis on adipokines relationship with COVID-19 severity, concomitant metabolic abnormalities and liver dysfunction. Serum chemerin, omentin and vaspin concentrations were measured in serum collected from 70 COVID-19 patients at the moment of admission to hospital, before any treatment was applied and 20 healthy controls. Serum chemerin and omentin concentrations were significantly decreased in COVID-19 patients compared to healthy volunteers (271.0 vs. 373.0 ng/ml; p < 0.001 and 482.1 vs. 814.3 ng/ml; p = 0.01, respectively). There were no correlations of analyzed adipokines with COVID-19 severity based on the presence of pneumonia, dyspnea, or necessity of Intensive Care Unit hospitalization (ICU). Liver test abnormalities did not influence adipokines levels. Elevated GGT activity was associated with ICU admission, presence of pneumonia and elevated concentrations of CRP, ferritin and interleukin 6. Chemerin and omentin depletion in COVID-19 patients suggests that this adipokines deficiency play influential role in disease pathogenesis. However, there was no relationship between lower adipokines level and frequency of COVID-19 symptoms as well as disease severity. The only predictive factor which could predispose to a more severe COVID-19 course, including the presence of pneumonia and ICU hospitalization, was GGT activity.Michał KuklaTomasz MenżykMarcin DembińskiMarek WiniarskiAleksander GarlickiMonika Bociąga-JasikMagdalena SkoniecznaDorota HudyBarbara MaziarzBeata Kusnierz-CabalaLubomir SkladanyIvica GrgurevicMałgorzata Wójcik-BugajskaTomasz GrodzickiDominika StygarTomasz RogulaNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-13 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Michał Kukla
Tomasz Menżyk
Marcin Dembiński
Marek Winiarski
Aleksander Garlicki
Monika Bociąga-Jasik
Magdalena Skonieczna
Dorota Hudy
Barbara Maziarz
Beata Kusnierz-Cabala
Lubomir Skladany
Ivica Grgurevic
Małgorzata Wójcik-Bugajska
Tomasz Grodzicki
Dominika Stygar
Tomasz Rogula
Anti-inflammatory adipokines: chemerin, vaspin, omentin concentrations and SARS-CoV-2 outcomes
description Abstract Coronavirus disease 2019 (COVID-19) is associated with systemic inflammation. A wide range of adipokines activities suggests they influence pathogenesis and infection course. The aim was to assess concentrations of chemerin, omentin, and vaspin among COVID-19 patients with an emphasis on adipokines relationship with COVID-19 severity, concomitant metabolic abnormalities and liver dysfunction. Serum chemerin, omentin and vaspin concentrations were measured in serum collected from 70 COVID-19 patients at the moment of admission to hospital, before any treatment was applied and 20 healthy controls. Serum chemerin and omentin concentrations were significantly decreased in COVID-19 patients compared to healthy volunteers (271.0 vs. 373.0 ng/ml; p < 0.001 and 482.1 vs. 814.3 ng/ml; p = 0.01, respectively). There were no correlations of analyzed adipokines with COVID-19 severity based on the presence of pneumonia, dyspnea, or necessity of Intensive Care Unit hospitalization (ICU). Liver test abnormalities did not influence adipokines levels. Elevated GGT activity was associated with ICU admission, presence of pneumonia and elevated concentrations of CRP, ferritin and interleukin 6. Chemerin and omentin depletion in COVID-19 patients suggests that this adipokines deficiency play influential role in disease pathogenesis. However, there was no relationship between lower adipokines level and frequency of COVID-19 symptoms as well as disease severity. The only predictive factor which could predispose to a more severe COVID-19 course, including the presence of pneumonia and ICU hospitalization, was GGT activity.
format article
author Michał Kukla
Tomasz Menżyk
Marcin Dembiński
Marek Winiarski
Aleksander Garlicki
Monika Bociąga-Jasik
Magdalena Skonieczna
Dorota Hudy
Barbara Maziarz
Beata Kusnierz-Cabala
Lubomir Skladany
Ivica Grgurevic
Małgorzata Wójcik-Bugajska
Tomasz Grodzicki
Dominika Stygar
Tomasz Rogula
author_facet Michał Kukla
Tomasz Menżyk
Marcin Dembiński
Marek Winiarski
Aleksander Garlicki
Monika Bociąga-Jasik
Magdalena Skonieczna
Dorota Hudy
Barbara Maziarz
Beata Kusnierz-Cabala
Lubomir Skladany
Ivica Grgurevic
Małgorzata Wójcik-Bugajska
Tomasz Grodzicki
Dominika Stygar
Tomasz Rogula
author_sort Michał Kukla
title Anti-inflammatory adipokines: chemerin, vaspin, omentin concentrations and SARS-CoV-2 outcomes
title_short Anti-inflammatory adipokines: chemerin, vaspin, omentin concentrations and SARS-CoV-2 outcomes
title_full Anti-inflammatory adipokines: chemerin, vaspin, omentin concentrations and SARS-CoV-2 outcomes
title_fullStr Anti-inflammatory adipokines: chemerin, vaspin, omentin concentrations and SARS-CoV-2 outcomes
title_full_unstemmed Anti-inflammatory adipokines: chemerin, vaspin, omentin concentrations and SARS-CoV-2 outcomes
title_sort anti-inflammatory adipokines: chemerin, vaspin, omentin concentrations and sars-cov-2 outcomes
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/ab7ee6424fed4bea89e7d91ef4bfec76
work_keys_str_mv AT michałkukla antiinflammatoryadipokineschemerinvaspinomentinconcentrationsandsarscov2outcomes
AT tomaszmenzyk antiinflammatoryadipokineschemerinvaspinomentinconcentrationsandsarscov2outcomes
AT marcindembinski antiinflammatoryadipokineschemerinvaspinomentinconcentrationsandsarscov2outcomes
AT marekwiniarski antiinflammatoryadipokineschemerinvaspinomentinconcentrationsandsarscov2outcomes
AT aleksandergarlicki antiinflammatoryadipokineschemerinvaspinomentinconcentrationsandsarscov2outcomes
AT monikabociagajasik antiinflammatoryadipokineschemerinvaspinomentinconcentrationsandsarscov2outcomes
AT magdalenaskonieczna antiinflammatoryadipokineschemerinvaspinomentinconcentrationsandsarscov2outcomes
AT dorotahudy antiinflammatoryadipokineschemerinvaspinomentinconcentrationsandsarscov2outcomes
AT barbaramaziarz antiinflammatoryadipokineschemerinvaspinomentinconcentrationsandsarscov2outcomes
AT beatakusnierzcabala antiinflammatoryadipokineschemerinvaspinomentinconcentrationsandsarscov2outcomes
AT lubomirskladany antiinflammatoryadipokineschemerinvaspinomentinconcentrationsandsarscov2outcomes
AT ivicagrgurevic antiinflammatoryadipokineschemerinvaspinomentinconcentrationsandsarscov2outcomes
AT małgorzatawojcikbugajska antiinflammatoryadipokineschemerinvaspinomentinconcentrationsandsarscov2outcomes
AT tomaszgrodzicki antiinflammatoryadipokineschemerinvaspinomentinconcentrationsandsarscov2outcomes
AT dominikastygar antiinflammatoryadipokineschemerinvaspinomentinconcentrationsandsarscov2outcomes
AT tomaszrogula antiinflammatoryadipokineschemerinvaspinomentinconcentrationsandsarscov2outcomes
_version_ 1718442651653505024